Bachri H, Essangri H, El Bahaoui N, Benkabbou A, Mohsine R, Majbar AM, Souadka A. External validation of the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer colorectal (CR29) module: Monocentric study. World J Methodol 2023; 13(4): 259-271 [PMID: 37771870 DOI: 10.5662/wjm.v13.i4.259]
Corresponding Author of This Article
Amine Souadka, MD, PhD, Professor, Surgical Oncology Department, National Institute of Oncology, Mohammed Vth University in Rabat, Hay riad Souissi, Rabat 10100, Morocco. a.souadka@um5r.ac.ma
Research Domain of This Article
Oncology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 2 Quality of life scores according to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and Quality of Life Questionnaire-CR29 structure and reliability
Scaling/single-item name
n
Item No.
Mean
SD
Floor
Ceiling
Range
ICC
EORTC QLQ-CR29
All patients
221
Urinary frequency
31.32
39.89
33.46
26.2
10.9
0-100
0.961
Blood & mucus in stool
38.39
24.73
29.02
43.4
4.1
0-100
0.969
(F) Body image
45-47
77.82
24.83
1.8
38
0-100
0.950
Defecation/stoma problems
49–54
-
-
-
-
-
Urinary incontinence
33
20.96
32.22
64.7
7.2
0-100
0.982
Dysuria
34
20.66
31.30
63.3
6.8
0-100
0.950
Abdominal pain
35
30.61
34.12
48
8.6
0-100
0.922
Buttock pain
36
27.14
34.62
55.7
9
0-100
0.921
Bloated feeling
37
28.80
33.77
50.2
8.6
0-100
0.945
Dry mouth
40
24.58
34.14
60.2
8.6
0-100
0.979
Hair loss
41
16.44
29.57
71.5
5.9
0-100
0.968
Trouble with taste
42
20.51
32.89
67.0
8.1
0-100
0.975
(F) Anxiety
43
64.67
37.60
16.7
43.4
0-100
0.951
(F) Weight
44
75.56
32.66
8.1
56.6
0-100
0.960
Patients with stoma
50
Flatulence
49s
41.49
33.00
28.6
10.2
0-100
0.908
Leakage
50 s
42.17
36.49
32.7
16.3
0-100
0.889
Sore skin around stoma
51s
42.85
38.49
34.5
20.4
0-100
0.965
Bags change
52.53 s
18.36
22.62
49
2
0-83
0.969
Embarrassed
54s
45.56
43.09
41.8
29.1
0-100
0.956
Stoma care pb
55s
40.08
41.47
46.8
21.5
0-100
0.912
Stoma pb
49-54s
37.41
20.18
4.1
4.1
0-100
0.999
Patients without stoma
172
Flatulence
49
30.62
37.01
52.9
12.8
0-100
0.980
Faecal incontinence
50
26.16
37.38
61.6
14.0
0-100
0.970
Sore skin around anus
51
20.34
31.72
64.5
7.6
0-100
0.979
Stool frequency
52.53
29.65
32.33
38.4
7.6
0-100
0.977
Embarrassment
54
31.20
38.51
54.7
15.1
0-100
0.975
Defecation pb
49-54
28.79
25.84
16.1
0.7
0-100
0.969
Male
123
Sexual functioning
56
42.85
37.81
33
20.5
0-100
0.928
Impotence
57
38.18
38.79
40.9
20
0-100
0.966
Female
98
Sexual functioning
58
67.06
36.76
11.9
48.8
0-100
0.933
Dyspareunia
59
26.58
35.75
58.3
10.7
0-100
0.985
C30
221
Physical function
1 - 5
73.64
23.85
0.9
23.9
0-100
-
Role function
6.7
62.92
37.00
13.3
39.0
0-100
-
Emotional function
21-24
67.24
30.77
4.1
30.7
0-100
-
Cognitive function
20. 25
83.94
23.45
0.5
58.3
0-100
-
Social function
26 . 27
79.58
28.93
3.7
57.3
0-100
-
Fatigue
10.12.18
30.98
29.17
27.1
2.8
0-100
-
Nausea and vomiting
14.15
7.79
17.16
78.0
0.5
0-83
-
Pain
9.19
24.31
29.72
46.8
3.7
0-100
-
Dyspnoea
8
21.10
30.59
62.4
4.6
0-100
-
Insomnia
11
27.67
35.25
56.4
9.2
0-100
-
Appetite loss
13
20.48
30.99
63.3
6.4
0-100
-
Constipation
16
27.52
33.97
53.8
1.4
0-100
-
Diarrhea
17
27.67
34.67
53.2
10.6
0-100
-
Financial difficulties
28
51.22
40.61
30.7
30.7
0-100
-
Table 3 Convergent and discriminant validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CR29
Citation: Bachri H, Essangri H, El Bahaoui N, Benkabbou A, Mohsine R, Majbar AM, Souadka A. External validation of the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer colorectal (CR29) module: Monocentric study. World J Methodol 2023; 13(4): 259-271